<DOC>
	<DOCNO>NCT02769572</DOCNO>
	<brief_summary>This multicenter , double-blinded , double-dummy , randomize control clinical trial evaluate efficacy moxibustion osteoarthritis knee .</brief_summary>
	<brief_title>Moxibustion Osteoarthritis Knee</brief_title>
	<detailed_description>Aim : To evaluate effectiveness moxibustion treatment patient osteoarthritis knee , respect relieve pain , improve dysfunction improve quality life well . Design : A multicentre , double-blinded , double-dummy , randomize control clinical study perform China . Eligible participant randomly assign moxibustion group ( real moxibustion plus placebo gel ) control group ( diclofenac sodium gel plus sham moxibustion ) 1:1 allocation ratio . Participants group receive 12 session real/sham moxibustion 4 week 3 acupoints ( ST35 , EX-LE4 , ST36 ) . Either diclofenac sodium gel placebo gel apply 4 g per knee 4 time daily 4 week . The whole study period 13 week , 1-week run-in period , 4-week treatment phase , 8-week follow-up phase . The primary outcome measure change global scale Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) end course . The secondary outcome include change subscales ( pain , stiffness , function ) WOMAC , Visual Analogue scale ( VAS ) Patient Global Assessment ( PGA ) . Safety assess every visit .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Male female , age 40 75 year , knee osteoarthritis diagnose accord American College Rheumatology criterion Radiologic confirmation osteoarthritis 1 knee ( KellgrenLawrence score 2 3 ) Had knee pain one knee ( ) longer 3 months'duration The average severity knee pain least 3 point a10point visual analogue scale ( VAS ) Never experience moxibustion trial Participants willing comply study protocol Participants agree sign consent form Subjects serious disease include cancer , uncontrolled hypertension , diabetes mellitus require insulin injection , lifethreatening cardiovascular neurological event , chronic respiratory disease , haemorrhagic disorder serious mental disease Subjects pain knee may cause inflammatory , malignant , autoimmune disease traumatic injury ; Subjects receive knee replacement surgery affect knee Subjects receive knee arthroscopy within past year , steroid hyaluronic acid injection knee joint within previous 3 month Subject currently participate another clinical trial Subjects receive physiotherapy treatment osteoarthritis knee pain ( exception nonsteroidal antiinflammatory drug ) previous 4 week ;</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Knee osteoarthritis</keyword>
	<keyword>moxibustion</keyword>
	<keyword>diclofenac sodium gel</keyword>
</DOC>